Ledebouriella (Saposhnikovia divaricata): A Comprehensive Reference
1. Identity and Nomenclature
Botanical and Chemical Names
Ledebouriella is the historically prevalent common name in Western herbal and dietary supplement contexts for the plant now recognized in modern botanical taxonomy as Saposhnikovia divaricata (Turcz.) Schischk. It belongs to the monotypic genus Saposhnikovia, a genus of flowering plants in the family Apiaceae (formerly Umbelliferae). Its only species is Saposhnikovia divaricata, known as fángfēng (防風, literally "protect against the wind") in Chinese, bangpung in Korean, and siler in English. The plant is still frequently referenced under the obsolete genus name Ledebouriella in many online sources devoted to traditional Chinese medicine.
It was first described as Stenocoelium divaricatum by Nikolai Turczaninow in 1844, and transferred to Saposhnikovia in 1951. Additional historical synonyms include Ledebouriella seseloides (Hoffm.) H.Wolff and Ledebouriella divaricata (Turcz.); the Flora of China (2005) cites it as Saposhnikovia divaricata. In Chinese pharmacopeial and scientific literature, the official drug name for the dried root is Radix Saposhnikoviae, while the herbal designation in TCM practice is Fang Feng.
Botanical Description and Natural Distribution
Saposhnikovia divaricata is a glabrous, much-branched, perennial herb arising from a branched, annular, tuberous rootstock up to 2 cm thick, with a crown surrounded by fibrous, remnant, sheathing bases of petioles; it reaches heights of 30–100 cm. In China, the plant is found in the provinces of Inner Mongolia, Hebei, Shandong, Henan, Shanxi, Shaanxi, Hunan, Heilongjiang, Jilin, and Liaoning. It also occurs in Russia, Mongolia, Korea, and Japan, growing on grassy and stony slopes at 400–800 m altitude, as well as on the margins of rice paddies, roadsides, and waste places.
Saposhnikovia divaricata is an important economic medicinal plant in eastern Asia and is classified as a National Grade III Key Protected Wild Medicinal Plant in China. Most of the plants harvested are collected in the provinces of Heilongjiang, Jilin, Inner Mongolia, and Hebei.
Common Dosage Forms and Preparations
The medicinal part is exclusively the dried root. The tuberous rootstocks are harvested in early spring or late autumn (when the plants have yet to flower or have finished flowering), washed, trimmed of basal leaves and fibrous roots, sun-dried until they contain 20% moisture, shredded, and then sun-dried again until completely desiccated and ready for storage. Preparations encountered in clinical and research contexts include:
- Decoction (water extract / tea): The most traditional form. Preparation involves removing residual stems, soaking in water, cutting into slices, and drying.
- Standardized ethanolic extract: Used in the majority of pharmacological research studies, often standardized to chromone content.
- Powdered root and capsules: Increasingly available in Western dietary supplement markets.
- Combination formula (Yu Ping Feng San): Yu Ping Feng San (YPFS), a Chinese herbal decoction, is composed of Astragali Radix (Huangqi), Atractylodis Macrocephalae Rhizoma (Baizhu), and Saposhnikoviae Radix (Fangfeng) in a weight ratio of 1:2:1.
2. Traditional and Historical Use
Origins in Chinese Medicine
Saposhnikovia divaricata, with a history of over 2,000 years in traditional Chinese medicine clinical practice, is a medicinal herb widely produced in various regions of China such as Heilongjiang, Jilin, Liaoning, Hebei, Shandong, and Inner Mongolia. It has a wide range of effects and is recorded as a superior herb in the ancient book Shennong Bencao Jing.
The root has been used since the Western Han Dynasty (202 B.C.). Its medical application was first reported in the Shennong's Classic of Materia Medica, the oldest pharmaceutical monograph of traditional Chinese medicine written during the reign of the Qin and Han Dynasties. In this monograph, Saposhnikoviae Radix usage was prescribed for treating dizziness, blindness, dysphoria, apoplexia, joint pain, and for providing relaxation to the body when used long-term.
It is classified as a special-grade traditional Chinese medicine in Shennong's Materia Medica due to its immune-protective effects, including dispelling cold, relieving edema and pain, and its potential in treating rheumatoid arthritis.
In ancient books such as the Shennong's Classic of Materia Medica, the use of Saposhnikoviae Radix is generally prescribed to dispel wind to release the exterior pattern, to dispel dampness, to relieve pain, and to arrest convulsions, which roughly corresponds to its modern applications.
Historical records spanning the Tang, Song, Ming, and Qing dynasties continued to document its use and production regions. The Tang Dynasty text Xinxiu Bencao (A.D. 657–659) recorded that the quality of Fang Feng produced in Shandong was appreciable. It was also produced in the Weinan area of Shaanxi Province, although its quality was lower than that produced in Shandong owing to its loose texture.
Traditional Indications in Chinese Medicine
Within the framework of Traditional Chinese Medicine (TCM), Fang Feng occupies the category of herbs that "release the exterior" and "expel wind." Its traditional functions include dispelling wind, relieving surface symptoms, eliminating dampness, alleviating pain, and relieving spasms. It has been used in China for the treatment of the common cold, headache, rheumatic diseases, arthralgia, rubella, pruritus, and tetanus.
Fang Feng was first recorded in the Shennong's Classic of Materia Medica, written around 300 AD China. It is generally prescribed to dispel wind to release the exterior pattern, dispel dampness, relieve pain, and arrest convulsions, which is roughly in line with modern applications.
TCM practitioners combined Fang Feng with other herbs in compound formulas. Over 130 traditional Chinese medicine formulations containing Saposhnikovia divaricata are used for rheumatoid arthritis treatment. The representative formula Yu Ping Feng San ("Jade Windscreen Powder," described in the Dan Xi Xin Fa by Zhu Danxi in the Yuan Dynasty, A.D. 1279–1368) paired the root with Astragalus and Atractylodes to tonify the Wei Qi and prevent recurrent respiratory infections.
Use in Korea and Japan
Owing to its efficacy, Saposhnikoviae Radix is a popular product worldwide, especially in Japan, Korea, Mongolia, and Russia. The root of Saposhnikovia divaricata has been widely used in traditional medicine for the treatment of headache, pain, inflammation, and arthritis in Korea and China. It is a traditional Chinese herb commonly used to treat clinical conditions such as rheumatism and allergic rhinitis.
Traditional Dosage (Historical Context)
The traditional dosage is 3–9 grams per day, with the main TCM actions described as relieving the exterior and dispersing cold, and relieving wind-damp-cold painful obstruction.
3. Key Constituents and Active Compounds
Overview of Phytochemistry
The dried root (Radix Saposhnikoviae) is used as a Chinese herbal medicine for the treatment of immune system, nervous system, and respiratory diseases. Phytochemical and pharmacological studies have shown that the main constituents of S. divaricata are chromones, coumarins, acid esters, and polyacetylenes. Studies have discovered that Saposhnikovia divaricata also contains chemical components such as polysaccharides and volatile oils.
Chromones (Primary Bioactive Class)
Chromones are widely considered the most pharmacologically significant constituents of the root. Major bioactive chromone constituents include prim-O-glucosylcimifugin, 4′-O-β-D-glucosyl-5-O-methylvisamminol, cimifugin, and sec-O-glucosylhamaudol, which are usually obtained from the roots of the plant.
Chromones are the major active ingredients in Fang Feng, consisting primarily of prim-O-glucosylcimifugin and cimifugin. Previous studies have demonstrated that prim-O-glucosylcimifugin exerts anti-inflammation and analgesia effects, and may be converted into cimifugin in vivo.
Early phytochemical investigations documented the compound now known as ledebouriellol — a chromone named after the plant's former genus. Three new chromones, named 3′-O-angeloylhamaudol, ledebouriellol, and 4′-O-β-D-glucosyl-5-O-methylvisamminol, were isolated from the root and rhizome of Ledebouriella seseloides WOLFF (Umbelliferae), together with five known coumarins and six known chromones.
More recent phytochemical screening has expanded the chromone inventory considerably. Fifteen new chromones, designated sadivamones A–E (1–5), cimifugin monoacetate (6), and sadivamones F–N (7–15), together with fifteen known chromones (16–30), were isolated from the ethyl acetate portions of a 70% ethanol extract of Saposhnikovia divaricata roots.
Coumarins
Coumarins represent the second major class. Eleven compounds were isolated from the methanolic extraction of the radix of Ledebouriella seseloides. They were identified as beta-sitosterol, bergapten, hamaudol, daucosterine, sec-O-glucosylhamaudol, 5-O-methylvisamminol, cimifugin, sucrose, 4-O-β-glucopyranosyl-5-O-methyl-visamminol, prim-O-glucosylcimifugin, and mannitol by physico-chemical constants and spectroscopic analysis. The roots and seeds also contain furocoumarins, furanochromones, polyacetylenes, hyperosides, and terpenes.
Polysaccharides and Lipophilic Components
In HPLC fingerprints of lipophilic components of Saposhnikovia divaricata, four components were characterized: linolenic acid (ALA), docosahexaenoic acid (DHA), linoleic acid (LA), and oleic acid (OA). Polysaccharides derived from the root have also been isolated and studied for biological activity, particularly in the context of immune modulation and anti-tumor research.
4. Established and Proposed Mechanisms of Action
Anti-Inflammatory Mechanisms
Saposhnikovia divaricata extract (SDE) showed anti-inflammatory activity by inhibiting the production of nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in LPS-induced RAW 264.7 cells.
Prim-O-glucosylcimifugin, the chromone with the highest content in the roots of S. divaricata, showed significant anti-inflammatory effects on LPS-induced inflammatory responses in RAW 264.7 cells and significantly protected mice against LPS-induced acute lung injury.
Chromone compounds isolated from S. divaricata can generate inhibition of rheumatoid arthritis via blocking NF-κB and MAPK activation in collagen-induced rheumatoid arthritis models. Multiple newly isolated chromones significantly inhibited the production of LPS-induced NO in macrophages; to determine the signaling pathways involved, ERK and c-Jun N-terminal protein kinase (JNK) expression was investigated by western blot analysis.
NF-κB and MAPK Pathways
Cimifugin is shown to inhibit allergic inflammatory responses by the modulation of tight junctions. Han et al. suggest that cimifugin protects against inflammatory cytokine production in an in vitro rheumatoid arthritis model. qPCR and Western blot analyses indicated that S. divaricata could down-regulate the Lyn/Syk/PLCγ, MAPK, and PI3K/AKT/NF-κB signal pathways to inhibit IgE-dependent cell degranulation.
Immunomodulatory Mechanisms
Treatment of YPFS (the formula containing Saposhnikoviae Radix) stimulated the mRNA and protein expressions of pro-inflammatory cytokines via activation of NF-κB by enhancing IκBα degradation in murine macrophages — illustrating the bidirectional, context-dependent nature of the immune modulation. In a lipopolysaccharide-induced chronic-inflammation model of cultured murine macrophages, YPFS treatment suppressed the activation of iNOS and COX-2 expression in a dose-dependent manner.
Rheumatoid Arthritis — TNF-α and RAGE Pathways
Among serum metabolites after S. divaricata administration, 17 compounds with anti-inflammatory activity were identified. The active ingredients and serum metabolites interfere with rheumatoid arthritis through TNF-α and RAGE signaling pathways, and the extract alleviated the progression of RA by regulating TNF-α and RAGE signaling.
Analgesic and Antipyretic Mechanisms
Modern pharmacological studies show that 4′-O-β-D-glucosyl-5-O-methylvisamminol in S. divaricata has obvious antipyretic, analgesic, anti-inflammatory, and anti-platelet aggregation effects. Chromone ketones are the main chemical components of S. divaricata and are the main active components in its antipyretic, analgesic, and anti-inflammatory effects.
5. Scientific Evidence by Area of Use
5.1 Inflammation and Rheumatoid / Osteoarthritis
Evidence type: predominantly preclinical (in vitro and animal models); limited human clinical data as an isolated herb.
The aim of a 2016 PMC study was to investigate the anti-inflammatory and anti-osteoarthritis activities of Saposhnikovia divaricata extract (SDE). The anti-inflammatory effect of SDE was evaluated in vitro in LPS-treated RAW 264.7 cells. The anti-osteoarthritic effect was investigated in an in vivo rat model of monosodium iodoacetate (MIA)-induced osteoarthritis, in which rats were treated orally with SDE (200 mg/kg) for 28 days. The effects of SDE were assessed in vivo by histopathological analysis and by measuring weight-bearing distribution, cytokine serum levels, and joint tissue inflammation-related gene expression. This was an animal model study and does not constitute clinical evidence.
A published study aimed to determine the anti-inflammatory activity of S. divaricata chromone extract (SCE) on collagen-induced arthritis (CIA) rats and to elucidate its underlying mechanisms with regard to its molecular basis of action on human fibroblast-like synoviocytes derived from RA patients (HFLS-RA). The CIA model was constructed by injection of bovine type II collagen. While this study used human-derived cells in part, the core model was a rodent arthritis model; it does not constitute a clinical trial.
A 2025 PMC study aimed to explore active ingredients and serum metabolites of S. divaricata using UPLC-Q-TOF-MS and investigate its therapeutic mechanisms in the context of RA. A total of 5,536 compounds were identified in the extract, and 19 active components were finally selected. In serum metabolites following administration, 4,945 compounds were identified, of which 17 showed anti-inflammatory activity. This was a mechanistic metabolomics study without a human clinical endpoint.
Overall: evidence for anti-arthritic effects of Saposhnikovia divaricata is substantial at the in vitro and animal level, supported by identification of plausible mechanisms (NF-κB, MAPK, TNF-α, RAGE suppression). Rigorous randomized controlled human trials evaluating the isolated herb for arthritis are lacking.
5.2 Immune Modulation and Respiratory Allergic Conditions
Evidence type: preclinical mechanistic studies; limited clinical data within multi-herb formulas.
Yu Ping Feng San (YPFS) is a classical TCM formulation which has been traditionally used for treatment of immune system-related diseases such as chronic bronchitis, allergic rhinitis, and asthma. In this formula, Saposhnikoviae Radix is one of three constituent herbs, making it impossible to isolate its contribution in clinical outcomes.
Limited clinical data suggest benefits of YPFS for allergic rhinitis and COPD. It was also effective in pediatric patients with asthma, although more data are needed to determine utility in those with allergic rhinitis. These findings pertain to the multi-herb formula, not to Fang Feng as a standalone ingredient.
At the mechanistic level, S. divaricata has various pharmacological activities, and a network pharmacology study evaluated the treatment and molecular mechanisms of SD against type I allergy (TIA). In a mouse passive cutaneous anaphylaxis (PCA) model, both SD and prim-O-glucosylcimifugin (POG) could dose-dependently attenuate Evans Blue extravasation, paw and ear swelling induced by DNP-IgE/DNP-BSA. The investigators concluded that SD is effective for the therapeutic treatment of type I allergies in the animal model, though the underlying mechanisms need further study.
Saposhnikovia divaricata could inhibit IgE-induced degranulation of mast cells, providing a scientific basis for further research and clinical applications of SD in type I allergy treatment. This conclusion is based on animal and cell-based data only.
5.3 Analgesic and Antipyretic Effects
Evidence type: preclinical (animal models).
Modern pharmacological studies have confirmed that Saposhnikovia divaricata has the functions of antipyretic, analgesic, anti-inflammatory, and antioxidant effects and promotes blood circulation. These findings are derived from animal and in vitro models. Pharmacological studies have shown that Saposhnikoviae Radix has antipyretic, analgesic, anti-inflammatory, antibacterial, anti-tumor, and other biological activities. No rigorous human clinical trials specifically assessing the analgesic or antipyretic efficacy of isolated S. divaricata preparations could be identified in the peer-reviewed literature.
5.4 Dermatological Applications — Psoriasis and Pruritus
Evidence type: single compound in vitro and mouse model studies.
The dry root of Saposhnikovia divaricata, also called Fang Feng, is a traditional Chinese herb that has anti-inflammatory and anti-allergic properties and is widely used as a drug in rheumatism, urticaria, and skin pruritus. Scientific investigation of cimifugin in a murine psoriasis model demonstrated effects via the NF-κB/MAPK pathway, but this remains a preclinical study only. No human clinical trials for psoriasis or pruritus using isolated S. divaricata were identified in the peer-reviewed sources consulted.
5.5 Anti-Tumor Properties
Evidence type: in vitro and animal xenograft models only; highly preliminary.
Saposhnikovia divaricata has been used in traditional Chinese medicine to treat pain, inflammation, and arthritis. It has been reported that SD extract may inhibit tumor growth, but the mechanism involved is elusive. A study aimed to investigate the anti-tumor activity of polysaccharides derived from SD in breast cancer and the underlying mechanisms.
In vitro studies showed that SD polysaccharides (SDPs) promoted U937 cell growth dose-dependently, with no obvious effect on growth of breast cancer cell lines MCF-7 and MDA-MB-231. At all tested concentrations, no obvious toxic side-effects were recorded. The investigators tentatively concluded that SDPs potently promote the growth of U937 cells and activate them to inhibit tumor growth of SCID mice bearing MDA-MB-231-derived xenograft tumors indirectly. Their finding indicated that SDP could be a potential anticancer agent for breast cancer. These are preclinical findings and cannot be extrapolated to human cancer treatment.
5.6 Migraine and Headache
Evidence type: network pharmacology and molecular docking (computational); no human clinical trials identified.
The Saposhnikovia divaricata–Angelica dahurica herb pair (SAHP) is frequently used in treating migraine and is a commonly used herb pair for migraine treatment in TCM practice. A PMC study investigated the molecular mechanism of the SAHP in migraine treatment by screening active ingredients and predicting potential targets using TCMSP, TCMID, ETCM, and other databases, with migraine-related targets obtained from GeneCards, DrugBank, OMIM, and TTD databases. This represents computational modeling, not clinical evidence.
5.7 Inflammatory Bowel Disease
Evidence type: in vitro cell culture models only.
Yu Ping Feng San, a Chinese herbal decoction comprising Astragali Radix, Atractylodis Macrocephalae Rhizoma, and Saposhnikoviae Radix, has been used clinically to treat inflammatory bowel diseases (IBD). One study elucidated the anti-inflammatory effect of YPFS mediated through modulating the expression of three key enzymes involved in IBD: inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and intestinal alkaline phosphatase (IALP). In a LPS-induced chronic-inflammation model of cultured murine macrophages, YPFS treatment suppressed the activation of iNOS and COX-2 expression in a dose-dependent manner. Human clinical data for S. divaricata or YPFS in confirmed IBD are absent from the peer-reviewed sources identified.
6. Body Systems and Health Areas of Association
Based on convergent traditional use and scientific investigation, the body systems most consistently associated with Saposhnikovia divaricata include:
- Musculoskeletal and connective tissue system: It is a traditional Chinese herb used to treat tetanus, rubella pruritus, rheumatic arthralgia, and other diseases. Research consistently documents anti-arthritic, analgesic, and anti-inflammatory activity in preclinical models.
- Immune system: As a perennial herb belonging to the family Umbelliferae, widely distributed in Northeast Asia, its dried root is used as a Chinese herbal medicine for the treatment of immune system, nervous system, and respiratory diseases.
- Integumentary system (skin): Traditional use in urticaria, pruritus, and skin-related wind-heat patterns is well-documented, and preclinical data on cimifugin's effects in psoriasis models support this application.
- Respiratory system: Use within Yu Ping Feng San for recurrent respiratory infections, chronic bronchitis, allergic rhinitis, and asthma is both historically documented and supported by limited clinical data for the formula as a whole.
- Nervous system: Traditional use for headache, convulsions, and tetanus is recorded; modern network pharmacology studies explore its role in migraine at the computational level.
7. Dosage Forms and Dosages Reported in Studies
The following dosages appear in the peer-reviewed sources identified; they describe research or traditional practice contexts and are presented as reported, not as recommendations:
- Traditional TCM decoction: 3–9 grams of dried root per day.
- Animal study — osteoarthritis model: Rats were treated orally with SDE (200 mg/kg) for 28 days.
- Cell culture study — type I allergy: RBL-2H3 cells were treated with different concentrations of SD (root decoction, 0.5, 1, and 2 mg/mL) and prim-O-glucosylcimifugin (POG, 10, 40, and 80 μg/mL).
- Yu Ping Feng San decoction preparation: According to the Danxi Xinfa prescription, crude materials in slices (50 g Astragali Radix, 150 g Atractylodis Macrocephalae Rhizoma, and 50 g Saposhnikoviae Radix) were combined with 3 times of distilled water (750 mL), soaked for 0.5 hour, then 5 times of water (1,250 mL) was added and refluxed for 1.5 hours at 100°C, filtered, and the filtrate collected.
Human clinical trials with precisely defined dosages of isolated Saposhnikovia divaricata preparations are absent from the current peer-reviewed literature base. Dosage data from animal studies cannot be directly translated to human use.
8. Safety Considerations and Interactions
General Safety Profile
Research on acute toxicity of water extract and water extracting-alcohol precipitating extract from Radix Saposhnikoviae has been conducted (Shang Y, Guan JH, Zhang YK, Shanxi J Tradit Chin Med, 2018). The published ethnopharmacological review on S. divaricata (PMC7176574) cites these toxicity studies but the detailed LD50 or clinical safety data from these sources were not available in full text for this article. In polysaccharide studies on breast cancer cell lines, at all tested concentrations, no obvious toxic side-effects were recorded.
Conservation and Adulteration Concerns
Saposhnikovia divaricata is an important economic medicinal plant in eastern Asia and is listed as a National Grade III Key Protected Wild Medicinal Plant in China. Growing market demand has driven both cultivation and the risk of adulteration. Molecular authentication methods including RAPD analysis have been applied to verify the identity of Ledebouriella seseloides in compound formulas such as Yu Ping Feng San.
Cytochrome P450 Interactions
Publications identified in systematic reviews of S. divaricata reference work examining the inhibitory potential of herbal medicines in the Umbelliferae family on human cytochrome P450-mediated oxidation (Okuyama et al., Jpn J Pharmacol, 2001). The discourse on the diverse class of chromones and coumarins in SD offers insight into the pharmacological effects of these bioactive constituents as anti-inflammatory, analgesic, immunoregulatory, antioxidative, and anti-proliferative agents. Given that coumarins and furocoumarins (such as bergapten) are present in the root, the potential for interactions with cytochrome P450 enzymes warrants attention in any formal pharmacokinetic assessment, though clinical drug interaction studies for isolated S. divaricata preparations were not identified in the peer-reviewed literature reviewed.
Use in Multi-Herb Formulas
Saposhnikoviae divaricata is a traditional Chinese herb commonly used to treat clinical conditions such as rheumatism and allergic rhinitis. In TCM practice, it is almost always administered as part of a multi-herb formula. SD is mostly used in compound preparations in the clinic. Safety assessments from compound formula studies may not be attributable to the isolated herb.
Conservation Status — Supply Risk
The continuously increasing market demand for traditional Chinese medicine requires the commercial cultivation of Saposhnikovia divaricata using standardized methods and high-yielding genotypes, such as double-headed root plants, for achieving consistent quality and a reliable supply. Wild-harvested material is subject to quality variation by provenance.
Evidence Gaps
Review articles evaluating a collection of works on in vitro and biochemical studies of SD consistently note that the body of evidence is composed overwhelmingly of in vitro and animal studies. The active ingredients and serum metabolites of S. divaricata remain underexplored, and its precise mechanism of action in RA is not fully understood. Formal pharmacovigilance data, drug–herb interaction studies in humans, and long-term safety data for standardized isolated preparations are not available in the current peer-reviewed literature.
Summary of Evidence Strength
- Traditional use: Well-documented across millennia in Chinese, Korean, Japanese, and Mongolian medical traditions, supported by classical textual sources.
- Phytochemical characterization: Robust; chromones (especially cimifugin and prim-O-glucosylcimifugin) and coumarins are well-characterized.
- In vitro pharmacology: Strong; consistent evidence for anti-inflammatory, immunomodulatory, and analgesic effects in cell-based models.
- Animal model data: Moderate; anti-arthritic, antipyretic, analgesic, and anti-allergic activity demonstrated in multiple rodent studies.
- Human clinical evidence (isolated herb): Absent or not yet published in accessible peer-reviewed form.
- Human clinical evidence (multi-herb formulas containing Fang Feng): Limited; Yu Ping Feng San has some clinical data for allergic rhinitis, asthma, and COPD, but the contribution of S. divaricata cannot be isolated.
References
Go back